The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Novartis (Inst)
A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs?
 
Floor Lubberman
No Relationships to Disclose
 
Hans Gelderblom
Patents, Royalties, Other Intellectual Property - Amgen, Boehringer-Ingelheim, Pfizer, Novartis, Pharmamar, Daiichi, Five Prime (Inst)
Other Relationship - Daiichi Sankyo
 
Paul Hamberg
No Relationships to Disclose
 
Walter Vervenne
No Relationships to Disclose
 
Sasja F. Mulder
No Relationships to Disclose
 
Frank Jansman
No Relationships to Disclose
 
Angela Colbers
No Relationships to Disclose
 
Winette T.A. Van Der Graaf
No Relationships to Disclose
 
David Burger
No Relationships to Disclose
 
Saskia Luelmo
No Relationships to Disclose
 
Dirk Jan A.R. Moes
Research Funding - Chiesi (Inst)
 
Carla M.L.- Van Herpen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck (Inst); Merck Sharp & Dome (Inst); Sanofi (Inst)
 
Nielka P. Van Erp
Research Funding - Astellas Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Ipsen (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)